Vital360Rx is built on the body of research evaluating how nutrition affects strength, treatment tolerance, and recovery in adults with cancer. We’ve synthesized 41 studies into a single review you can read or download.
A 2025 meta-analysis of 29 RCTs (n=2,279) found high-protein oral nutritional supplements significantly reduced complications by 101 per 1,000 patients and shortened hospital length of stay across multiple cancer types.
A 2024 meta-analysis of high-protein supplementation during cancer therapy showed consistent improvements in muscle strength and decreased hospitalization rates.
A 2023 individual patient data meta-analysis found a 12% reduction in cancer mortality with daily vitamin D3 supplementation; a 2024 umbrella review of 71 systematic reviews supported a 10% reduction in total cancer mortality.
A 2024 review of 34 RCTs (n=2,580) showed curcumin supplementation reduced inflammatory biomarkers and improved mucositis-related outcomes.
Multiple meta-analyses support glutamine and zinc for reducing oral mucositis incidence and severity — important because mucositis is one of the leading reasons patients can’t eat enough during treatment.
Different ingredients address different pieces of the same problem: protein for muscle, anti-inflammatories for systemic burden, mucosal-support nutrients for intake, and micronutrients for stability.
We’re committed to keeping our claims tight to the evidence, so it’s worth being clear about what this review does not establish:
Methods, results by intervention category, discussion, limitations, and complete references — available as a PDF.